Treatment of pain in patients with osteoarthritis of different location

Abstract

Currently, the use of drugs which can modify metabolic processes in the cartilage attracts increasing attention, primarily because of their high safety profile. The article presents data on the use of combined drugs Theraflex and Theraflex Advance in the treatment of patients with degenerative-dystrophic diseases of the joints and spine.

Keywords

• остеоартроз
• модифицирующие средства замедленного действия
• глюкозамин
• хондроитина сульфат
• ибупрофен
• osteoarthritis
• delayed-action modifying agents
• glucosamine
• chondroitin sulfate
• ibuprofen